Sowell Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,963
| Closed | -$62K | – | 532 |
|
|
2021
Q1 | $62K | Buy |
2,963
+348
| +13% | +$7.28K | ﹤0.01% | 1554 |
|
|
2020
Q4 | $140K | Buy |
2,615
+805
| +44% | +$43.1K | 0.01% | 1010 |
|
|
2020
Q3 | $75K | Sell |
1,810
-811
| -31% | -$33.6K | ﹤0.01% | 1078 |
|
|
2020
Q2 | $127K | Buy |
2,621
+867
| +49% | +$42K | 0.01% | 893 |
|
|
2020
Q1 | $74K | Buy |
1,754
+258
| +17% | +$10.9K | 0.01% | 925 |
|
|
2019
Q4 | $64K | Buy |
+1,496
| New | +$64K | ﹤0.01% | 1063 |
|